Soluble forms of the selectin family in children with Kawasaki disease: Prediction for coronary artery lesions

Acta Paediatrica, International Journal of Paediatrics

Volumn 91, Issue 11, 2002, Pages 1183-1188

  Furui, J ^a   Ishii, M ^a   Ikeda, H ^a   Muta, H ^a   Egami, K ^a   Sugahara, Y ^a   Himeno, W ^a   Akagi, T ^a   Kato, H ^a   Matsuishi, T ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary artery lesions; Kawasaki disease; Selectin family; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN; PADGEM PROTEIN; PARACETAMOL; SELECTIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOTHERAPY; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FAMILY; SENSITIVITY AND SPECIFICITY; VASCULITIS;

CHILD; CHILD, PRESCHOOL; CORONARY DISEASE; E-SELECTIN; FEMALE; HUMANS; INFANT; KINETICS; LOGISTIC MODELS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; SOLUBILITY;

EID: 18744401875     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/080352502320777414     Document Type: Article

References (29)

1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54: 271-6
2. Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr 1975; 86: 892-8
3. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease: 10- To 21 year follow-up study of 594 patients. Circulation 1996; 94: 1379-85
4. Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease: Clinical analyses in 195 cases. J Pediatr 1986; 108: 923-7
5. Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G, Iemura M, et al. Coronary endothelium dysfunction after Kawasaki disease: Evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol 1998; 31: 1074-108
6. Iemura M, Ishii M, Sugimura T, Akagi T, Kato H. Long-term consequences of regressed coronary aneurysms after Kawasaki disease: Vascular wall morphology and function. Heart 2000; 83: 307-11
7. Ueyama T, Ikeda H, Haramaki N, Kuwano K, Imaizumi T. Effects of monoclonal antibody to P-selectin and analogue of sialyl Lewis X on cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. Circulation 1997; 95: 1554-9
8. Ikeda H, Ueyama T, Murohara T, Yasukawa H, Haramaki N, Eguchi H, et al. Adhesive interaction between P-selectin and sialyl Lewis X plays an important role in recurrent coronary arterial thrombosis in dogs. Arterioscler Thromb Vasc Biol 1999; 19: 1083-90
9. Timothy M, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-101
10. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-12
11. Kansas GS. Selectins and their ligands: Current concepts and controversies. Blood 1996; 88: 3259-87
12. Ikeda H, Ueyama T, Murohara T, Yasukawa H, Haramaki N, Eguchi H, et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995; 92: 1693-6
13. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rate: Distinction from and prerequisite for adhesion through integrins. Cell 1991: 859-73
14. Yeo EL, Sheppard JAI, Feuerstein IA. Role of P-selectin and leukocyte activation in polymorphonuclear cell adhesion to surface adherent activated platelets under physiologic conditions (an injury vessel wall model). Blood 1994; 83: 2498-507
15. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978; 61: 17-27
16. Sasaguri Y, Kato H. Regression of aneurysms in Kawasaki disease: A pathological study. J Pediatr 1982; 100: 225-31
17. Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: Immunohistochemical study. Circulation 2000; 101: 2935-41
18. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease. Diagnostic guidelines for Kawasaki disease. Am J Dis Child 1990; 144: 1218-9
19. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315: 341-7
20. Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 2001; 43: 211-7
21. Kim DS, Lee KY. Serum soluble E-selectin levels in Kawasaki disease. Scand J Rheumatol 1994; 23: 283-6
22. Takeshita S, Dobashi H, Nakatani K, Koike Y, Tsujimoto H, Hirayama K, et al. Circulating soluble selectins in Kawasaki disease. Clin Exp Immunol 1997; 108: 446-50
23. Schiller B, Elinder G. Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: Relationship to cardiac lesions and intravenous immunoglobulin treatment. Acta Paediatr 1999; 88: 844-8
24. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. High-dose intravenous gamma globulin for Kawasaki disease. Lancet 1984; ii: 1055-8
25. Sato N, Sugimura T, Akagi T, Yamakawa R, Hashino K, Eto G, et al. Selective high dose gamma-globulin treatment in Kawasaki disease: Assessment of clinical aspects and cost effectiveness. Pediatr Int 1999; 41: 1-7
26. Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajima I, et al. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 1998: 596-9
27. Lin CY, Lin CC, Hwang B, Chiang BN. Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur J Pediatr 1993; 152: 309-12
28. Ohnishi M, Imanishi N, Tojo SJ. Protective effect of anti-P-selectin monoclonal antibody in lipopolysaccharide-induced lung hemorrhage. Inflammation 1999; 23: 461-9
29. Schlag G, Redl HR, Till GO, Davies J, Martin U, Dumont L. Anti-L-selectin antibody treatment of hemorrhagic-traumatic shock in baboons. Crit Care Med 1999; 27: 1900-7